Determine the effect of higher versus standard dose influenza vaccine on AKI
X-axis is the relative Risk Reduction for High Dose Vaccine (\(1 - p_H / p_S\)). Each curve assumes a proportion of AKI hospitalization over All hospitalization. Therefore, total AKI hospitalization will be calculated by 1296 (composite events for main trial) TIMES 0.7 (70% hospitalization, 30% death) TIMES AKI hosp rate (each curve) DIVIDED BY 9300 (total number of subjects in the main trial) * 8800 (total number of subjects in our trial). Power is calculated by comparing two proportions.
Determine the effect of higher versus standard dose influenza vaccine on death/cardiopulmonary hospitalizations in patients with CKD
X-axis is the relative Risk Reduction for High Dose Vaccine (\(1 - p_H / p_S\)). Each curve assumes a proportion of CKD population in the whole cohort. Power is calculated by comparing two proportions.
3.1 Higher vs standard is associated with greater frequency of adequate immune response, as assessed by doubling of geometric mean antibody titers at 4 weeks
Outcomes: Doubling of geometric mean titer (present or absent)
3.3: Influenza vaccination is associated with the development of anti-HLA antibodies
Outcomes: De novo anti HLA antibodies (present or absent)
I combined session 3.1 and 3.2 because both of them are comparing High versus Standard with an binary outcome. Each curve represent proportion of “present” in the standard dose, and X-axis is the relative Risk Reduction for High Dose Vaccine (\(1 - p_H / p_S\)). Power is calculated by comparing two proportions.